BioNTech SE Effect Of Exchange Rate Changes On Cash And Cash Equivalents
BioNTech SE (BNTX) reported Effect Of Exchange Rate Changes On Cash And Cash Equivalents of -EUR 27.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Cash Flow
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents · last filed 2026-03-10
| Period end | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month as first filed |
|---|---|---|
| 2025-12-31 | -27.00M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 14.80M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | -14.50M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 60.10M EUR 20-F · filed 2025-03-10 | 59.60M EUR 20-F · filed 2023-03-27 |
| 2021-12-31 | 64.70M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | -45.30M EUR 20-F · filed 2023-03-27 | -45.34M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 0.00 EUR 20-F/A · filed 2022-10-26 | 16.00K EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | -459.00K EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | -24.82M EUR 20-F · filed 2020-03-31 |